June 2020: COVID-19 and Male Reproductive Health and Trophectoderm Biopsy

Journal Club Global

Like Comment

For the first part of this event, Jim Hotaling, M.D., and Jingtao Guo, Ph.D., are joined by Michael Eisenberg, M.D., to discuss the recent Fertility and Sterility manuscript, “No evidence of SARS-CoV-2 in semen of males recovering from COVID-19." For the second part of this event, Patrizia Rubino, M.S, Bradford Kolb, M.D., and Tih Tan, M.S., E.L.D, are joined by Tex VerMilyea, Ph.D., HCLD, to discuss the recent Fertility and Sterility manuscript, “Trophectoderm biopsy protocols can affect clinical outcomes: time to focus on the blastocyst biopsy technique."

Questions and issues addressed during the event include:

  • What is the current evidence to support transport of COVID-19 in ART?
  • How can the ART lab limit transmission to patients and staff?
  • What is the rationale for hatching on day 3 prior to biopsy on day 5?
  • Does trophectoderm biopsy technique affect euploid rate?
  • How does trophectoderm biopsy technique affect clinical pregnancy rate?

This Journal Club Global is hosted by Fertility and Sterility Interactive Associate-In-Chief, Micah Hill, D.O., and by Fertility and Sterility's Video and New Media Editor, Kurt Barnhart, M.D., M.S.C.E.

Register to view the event here: httpshttps://www.workcast.com/register?cpak=8234721692965789

View the archive for all Journal Club Global videos here: https://www.fertstert.org/content/video.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.